Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease

Medical Clinics of North America

Volumn 97, Issue 3, 2013, Pages 399-424

  Teipel, Stefan J ^a,b   Grothe, Michel ^b   Lista, Simone ^c   Toschi, Nicola ^d   Garaci, Francesco G ^d,e   Hampel, Harald ^c  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Alzheimer disease; Diffusion spectrum imaging; Diffusion tensor imaging; Functional magnetic resonance imaging; Magnetic resonance imaging; Multimodal imaging; Preclinical diagnosis; Prediction

Indexed keywords

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; BOLD SIGNAL; BRAIN ATROPHY; BRAIN SIZE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DENTATE GYRUS; DENTATE HILUS; DIAGNOSTIC ACCURACY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; ECHO PLANAR IMAGING; ENTORHINAL CORTEX; FUNCTIONAL DISEASE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GRAY MATTER; HIPPOCAMPAL CA1 REGION; HUMAN; IMAGE PROCESSING; MACHINE LEARNING; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY (TOPIC); NERVE CELL NETWORK; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATTERN RECOGNITION; POSTERIOR CINGULATE; PRECUNEUS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR CORTEX; SUBICULUM; VOLUMETRY; VOXEL BASED MORPHOMETRY;

ALZHEIMER DISEASE; ASYMPTOMATIC DISEASES; ATROPHY; BRAIN; CEREBRAL CORTEX; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; DISEASE PROGRESSION; EARLY DIAGNOSIS; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIVARIATE ANALYSIS; NERVE DEGENERATION; NERVE NET; NEURONS; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84877074899     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.12.013     Document Type: Review

References (204)

1. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995, 16(3):271-278. [discussion: 278-84].
2. Thal D.R., Capetillo-Zarate E., Del Tredici K., et al. The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowledge Environ 2006, 2006(6):re1.
3. Albert M.S., DeKosky S.T., Dickson D., et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7(3):270-279.
4. Dubois B., Feldman H.H., Jacova C., et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010, 9(11):1118-1127.
5. Sperling R.A., Aisen P.S., Beckett L.A., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7(3):280-292.
6. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
7. McKhann G.M., Albert M.S., Grossman M., et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001, 58(11):1803-1809.
8. Golde T.E. Alzheimer disease therapy: can the amyloid cascade be halted?. J Clin Invest 2003, 111(1):11-18.
9. Bobinski M., de Leon M.J., Wegiel J., et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000, 95(3):721-725.
10. Giannakopoulos P., Kovari E., Gold G., et al. Pathological substrates of cognitive decline in Alzheimer's disease. Front Neurol Neurosci 2009, 24:20-29.
11. Hampel H., Frank R., Broich K., et al. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 2010, 9(7):560-574.
12. Giedd J.N., Kozuch P., Kaysen D., et al. Reliability of cerebral measures in repeated examinations with magnetic resonance imaging. Psychiatry Res 1995, 61(2):113-119.
13. Byrum C.E., MacFall J.R., Charles H.C., et al. Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method. Psychiatry Res 1996, 67(3):215-234.
14. Ewers M., Teipel S.J., Dietrich O., et al. Multicenter assessment of reliability of cranial MRI. Neurobiol Aging 2006, 27(8):1051-1059.
15. Zarow C., Vinters H.V., Ellis W.G., et al. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol 2005, 57(6):896-903.
16. Freeman S.H., Kandel R., Cruz L., et al. Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease. J Neuropathol Exp Neurol 2008, 67(12):1205-1212.
17. Scheltens P., Leys D., Barkhof F., et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatr 1992, 55:967-972.
18. Wahlund L.O., Julin P., Johansson S.E., et al. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatr 2000, 69(5):630-635.
19. Ridha B.H., Barnes J., van de Pol L.A., et al. Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Arch Neurol 2007, 64(6):849-854.
20. Bresciani L., Rossi R., Testa C., et al. Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry. Aging Clin Exp Res 2005, 17(1):8-13.
21. Seab J.P., Jagust W.J., Wong S.T., et al. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 1988, 8(2):200-208.
22. Killiany R.J., Moss M.B., Albert M.S., et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993, 50(9):949-954.
23. Csernansky J.G., Hamstra J., Wang L., et al. Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Dis Assoc Disord 2004, 18(4):190-195.
24. Lehericy S., Baulac M., Chiras J., et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer's disease. AJNR Am J Neuroradiol 1994, 15:927-937.
25. Teipel S.J., Pruessner J.C., Faltraco F., et al. Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI. J Neurol 2006, 253(6):794-800.
26. Rusinek H., de Leon M.J., George A.E., et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology 1991, 178(1):109-114.
27. Teipel S.J., Bayer W., Alexander G.E., et al. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging 2003, 24(1):85-94.
28. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256(3):183-194.
29. Guillozet A.L., Weintraub S., Mash D.C., et al. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003, 60(5):729-736.
30. Convit A., De Leon M.J., Tarshish C., et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 1997, 18(2):131-138.
31. Convit A., de Asis J., de Leon M.J., et al. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 2000, 21(1):19-26.
32. Du A.T., Schuff N., Amend D., et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatr 2001, 71(4):441-447.
33. Jack C.R., Petersen R.C., Xu Y.C., et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999, 52(7):1397-1403.
34. Killiany R.J., Hyman B.T., Gomez-Isla T., et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002, 58(8):1188-1196.
35. deToledo-Morrell L., Stoub T.R., Bulgakova M., et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 2004, 25(9):1197-1203.
36. Devanand D.P., Pradhaban G., Liu X., et al. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007, 68(11):828-836.
37. Krasuski J.S., Alexander G.E., Horwitz B., et al. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 1998, 43:60-68.
38. Pennanen C., Kivipelto M., Tuomainen S., et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004, 25(3):303-310.
39. Xu Y., Jack C.R., O'Brien P.C., et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000, 54(9):1760-1767.
40. Risacher S.L., Saykin A.J., West J.D., et al. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res 2009, 6(4):347-361.
41. Kaye J.A., Swihart T., Howieson D., et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997, 48(5):1297-1304.
42. den Heijer T., Geerlings M.I., Hoebeek F.E., et al. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 2006, 63(1):57-62.
43. Martin S.B., Smith C.D., Collins H.R., et al. Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment. Neurobiol Aging 2010, 31(7):1099-1106.
44. Frisoni G.B., Jack C.R. Harmonization of magnetic resonance-based manual hippocampal segmentation: a mandatory step for wide clinical use. Alzheimers Dement 2011, 7(2):171-174.
45. Chupin M., Gerardin E., Cuingnet R., et al. Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI. Hippocampus 2009, 19(6):579-587.
46. Mueller S.G., Weiner M.W. Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus 2009, 19(6):558-564.
47. Hanseeuw B.J., Van Leemput K., Kavec M., et al. Mild cognitive impairment: differential atrophy in the hippocampal subfields. AJNR Am J Neuroradiol 2011, 32(9):1658-1661.
48. Kerchner G.A., Deutsch G.K., Zeineh M., et al. Hippocampal CA1 apical neuropil atrophy and memory performance in Alzheimer's disease. Neuroimage 2012, 63(1):194-202.
49. Wang L., Beg F., Ratnanather T., et al. Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type. IEEE Trans Med Imaging 2007, 26(4):462-470.
50. Gerardin E., Chetelat G., Chupin M., et al. Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage 2009, 47(4):1476-1486.
51. Tondelli M., Wilcock G.K., Nichelli P., et al. Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging 2012, 33(4):825.e25-825.e36.
52. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. Neuroimage 2000, 11(6 Pt 1):805-821.
53. Fischl B., van der Kouwe A., Destrieux C., et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004, 14(1):11-22.
54. Klein A., Andersson J., Ardekani B.A., et al. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 2009, 46(3):786-802.
55. Leung K.K., Barnes J., Ridgway G.R., et al. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage 2010, 51(4):1345-1359.
56. Colliot O., Chetelat G., Chupin M., et al. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 2008, 248(1):194-201.
57. Mak H.K., Zhang Z., Yau K.K., et al. Efficacy of voxel-based morphometry with DARTEL and standard registration as imaging biomarkers in Alzheimer's disease patients and cognitively normal older adults at 3.0 Tesla MR imaging. J Alzheimers Dis 2011, 23(4):655-664.
58. Calvini P., Chincarini A., Gemme G., et al. Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. Med Phys 2009, 36(8):3737-3747.
59. Desikan R.S., Cabral H.J., Hess C.P., et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain 2009, 132(Pt 8):2048-2057.
60. Lerch J.P., Pruessner J., Zijdenbos A.P., et al. Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls. Neurobiol Aging 2008, 29(1):23-30.
61. Querbes O., Aubry F., Pariente J., et al. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 2009, 132(Pt 8):2036-2047.
62. Bakkour A., Morris J.C., Dickerson B.C. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009, 72(12):1048-1055.
63. Bookstein F.L. "Voxel-based morphometry" should not be used with imperfectly registered images. Neuroimage 2001, 14(6):1454-1462.
64. Ashburner J., Friston K.J. Why voxel-based morphometry should be used. Neuroimage 2001, 14(6):1238-1243.
65. Whitwell J.L., Josephs K.A., Murray M.E., et al. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology 2008, 71(10):743-749.
66. Di Paola M., Macaluso E., Carlesimo G.A., et al. Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study. J Neurol 2007, 254(6):774-781.
67. Grossman M., McMillan C., Moore P., et al. What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain 2004, 127(Pt 3):628-649.
68. Josephs K.A., Whitwell J.L., Duffy J.R., et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology 2008, 70(1):25-34.
69. Gee J., Ding L., Xie Z., et al. Alzheimer's disease and frontotemporal dementia exhibit distinct atrophy-behavior correlates: a computer-assisted imaging study. Acad Radiol 2003, 10(12):1392-1401.
70. Frisoni G.B., Testa C., Zorzan A., et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatr 2002, 73(6):657-664.
71. Karas G.B., Burton E.J., Rombouts S.A., et al. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 2003, 18(4):895-907.
72. Whitwell J.L., Przybelski S.A., Weigand S.D., et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007, 130(Pt 7):1777-1786.
73. Ries M.L., Carlsson C.M., Rowley H.A., et al. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc 2008, 56(5):920-934.
74. Chetelat G., Landeau B., Eustache F., et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005, 27(4):934-946.
75. Risacher S.L., Shen L., West J.D., et al. Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging 2010, 31(8):1401-1418.
76. Hall A.M., Moore R.Y., Lopez O.L., et al. Basal forebrain atrophy is a presymptomatic marker for Alzheimer's disease. Alzheimers Dement 2008, 4(4):271-279.
77. Driscoll I., Davatzikos C., An Y., et al. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology 2009, 72(22):1906-1913.
78. Csernansky J.G., Wang L., Swank J., et al. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 2005, 25(3):783-792.
79. Heckemann R.A., Keihaninejad S., Aljabar P., et al. Automatic morphometry in Alzheimer's disease and mild cognitive impairment. Neuroimage 2011, 56(4):2024-2037.
80. Barnes J., Foster J., Boyes R.G., et al. A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. Neuroimage 2008, 40(4):1655-1671.
81. Bartus R.T., Dean R.L., Pontecorvo M.J., et al. The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann N Y Acad Sci 1985, 444:332-358.
82. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?. Learn Mem 2004, 11(1):43-49.
83. Huckman M.S. Where's the chicken?. AJNR Am J Neuroradiol 1995, 16(10):2008-2009.
84. Hanyu H., Asano T., Sakurai H., et al. MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. AJNR Am J Neuroradiol 2002, 23(1):27-32.
85. Teipel S.J., Flatz W.H., Heinsen H., et al. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain 2005, 128(Pt 11):2626-2644.
86. Zaborszky L., Hoemke L., Mohlberg H., et al. Stereotaxic probabilistic maps of the magnocellular cell groups in human basal forebrain. Neuroimage 2008, 42(3):1127-1141.
87. Grothe M., Heinsen H., Teipel S.J. Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer's disease. Biol Psychiatry 2012, 71(9):805-813.
88. Teipel S.J., Meindl T., Grinberg L., et al. The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study. Hum Brain Mapp 2011, 32(9):1349-1362.
89. Basser P.J., Jones D.K. Diffusion-tensor MRI: theory, experimental design and data analysis-a technical review. NMR Biomed 2002, 15(7-8):456-467.
90. Bozzali M., Cherubini A. Diffusion tensor MRI to investigate dementias: a brief review. Magn Reson Imaging 2007, 25(6):969-977.
91. Chua T.C., Wen W., Slavin M.J., et al. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurol 2008, 21(1):83-92.
92. Hess C.P. Update on diffusion tensor imaging in Alzheimer's disease. Magn Reson Imaging Clin N Am 2009, 17(2):215-224.
93. Jones D.K., Leemans A. Diffusion tensor imaging. Methods Mol Biol 2011, 711:127-144.
94. Giannelli M., Belmonte G., Toschi N., et al. Technical note: DTI measurements of fractional anisotropy and mean diffusivity at 1.5 T: comparison of two radiofrequency head coils with different functional designs and sensitivities. Med Phys 2011, 38(6):3205-3211.
95. Jones D.K. Studying connections in the living human brain with diffusion MRI. Cortex 2008, 44(8):936-952.
96. Medina D., DeToledo-Morrell L., Urresta F., et al. White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol Aging 2006, 27(5):663-672.
97. Liu Y., Spulber G., Lehtimaki K.K., et al. Diffusion tensor imaging and tract-based spatial statistics in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2011, 32(9):1558-1571.
98. O'Dwyer L., Lamberton F., Bokde A.L., et al. Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease. PLoS One 2011, 6(6):e21745.
99. Fjell A.M., Amlien I.K., Westlye L.T., et al. Mini-mental state examination is sensitive to brain atrophy in Alzheimer's disease. Dement Geriatr Cogn Disord 2009, 28(3):252-258.
100. Heo J.H., Lee S.T., Kon C., et al. White matter hyperintensities and cognitive dysfunction in Alzheimer disease. J Geriatr Psychiatry Neurol 2009, 22(3):207-212.
101. Teipel S.J., Meindl T., Wagner M., et al. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis 2010, 22(2):507-522.
102. Chua T.C., Wen W., Chen X., et al. Diffusion tensor imaging of the posterior cingulate is a useful biomarker of mild cognitive impairment. Am J Geriatr Psychiatry 2009, 17(7):602-613.
103. Takahashi S., Yonezawa H., Takahashi J., et al. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett 2002, 332(1):45-48.
104. Zhang L., Dean D., Liu J.Z., et al. Quantifying degeneration of white matter in normal aging using fractal dimension. Neurobiol Aging 2007, 28(10):1543-1555.
105. Zhuang L., Wen W., Zhu W., et al. White matter integrity in mild cognitive impairment: a tract-based spatial statistics study. Neuroimage 2010, 53(1):16-25.
106. Douaud G., Jbabdi S., Behrens T.E., et al. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage 2011, 55(3):880-890.
107. Ennis D.B., Kindlmann G. Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images. Magn Reson Med 2006, 55(1):136-146.
108. Stricker N.H., Schweinsburg B.C., Delano-Wood L., et al. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. Neuroimage 2009, 45(1):10-16.
109. Teipel S.J., Stahl R., Dietrich O., et al. Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage 2007, 34(3):985-995.
110. Sexton C.E., Kalu U.G., Filippini N., et al. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2011, 32(12):2322. e5-e18.
111. Teipel S.J., Wegrzyn M., Meindl T., et al. Anatomical MRI and DTI in the diagnosis of Alzheimer's disease: a European multicenter Study. J Alzheimers Dis 2012, 31(0):S33-S47.
112. Alexander A.L., Hasan K.M., Lazar M., et al. Analysis of partial volume effects in diffusion-tensor MRI. Magn Reson Med 2001, 45(5):770-780.
113. Wedeen V.J., Wang R.P., Schmahmann J.D., et al. Diffusion spectrum magnetic resonance imaging (DSI) tractography of crossing fibers. Neuroimage 2008, 41(4):1267-1277.
114. Fieremans E., Jensen J.H., Helpern J.A. White matter characterization with diffusional kurtosis imaging. Neuroimage 2011, 58(1):177-188.
115. Hui E.S., Cheung M.M., Qi L., et al. Advanced MR diffusion characterization of neural tissue using directional diffusion kurtosis analysis. Conf Proc IEEE Eng Med Biol Soc 2008, 2008:3941-3944.
116. Jensen J.H., Helpern J.A. Progress in diffusion-weighted imaging: concepts, techniques and applications to the central nervous system. NMR Biomed 2010, 23(7):659-660.
117. Alexander D.C. Multiple-fiber reconstruction algorithms for diffusion MRI. Ann N Y Acad Sci 2005, 1064:113-133.
118. Assaf Y., Blumenfeld-Katzir T., Yovel Y., et al. AxCaliber: a method for measuring axon diameter distribution from diffusion MRI. Magn Reson Med 2008, 59(6):1347-1354.
119. Assaf Y., Basser P.J. Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain. Neuroimage 2005, 27(1):48-58.
120. Alexander D.C., Hubbard P.L., Hall M.G., et al. Orientationally invariant indices of axon diameter and density from diffusion MRI. Neuroimage 2010, 52(4):1374-1389.
121. De Santis S., Gabrielli A., Bozzali M., et al. Anisotropic anomalous diffusion assessed in the human brain by scalar invariant indices. Magn Reson Med 2011, 65(4):1043-1052.
122. De Santis S., Gabrielli A., Palombo M., et al. Non-Gaussian diffusion imaging: a brief practical review. Magn Reson Imaging 2011, 29(10):1410-1416.
123. 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006, 67(3):446-452.
124. Iraji A., Davoodi-Bojd E., Soltanian-Zadeh H., et al. Diffusion kurtosis imaging discriminates patients with white matter lesions from healthy subjects. Conf Proc IEEE Eng Med Biol Soc 2011, 2011:2796-2799.
125. Falangola M.F., Jensen J.H., Babb J.S., et al. Age-related non-Gaussian diffusion patterns in the prefrontal brain. J Magn Reson Imaging 2008, 28(6):1345-1350.
126. Wang J.J., Lin W.Y., Lu C.S., et al. Parkinson disease: diagnostic utility of diffusion kurtosis imaging. Radiology 2011, 261(1):210-217.
127. Bookheimer S.Y., Strojwas M.H., Cohen M.S., et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000, 343(7):450-456.
128. Borghesani P.R., Johnson L.C., Shelton A.L., et al. Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers. Neurobiol Aging 2008, 29(7):981-991.
129. Filippini N., MacIntosh B.J., Hough M.G., et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A 2009, 106(17):7209-7214.
130. Golby A., Silverberg G., Race E., et al. Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory. Brain 2005, 128(Pt 4):773-787.
131. Gron G., Bittner D., Schmitz B., et al. Hippocampal activations during repetitive learning and recall of geometric patterns. Learn Mem 2001, 8(6):336-345.
132. Hamalainen A., Pihlajamaki M., Tanila H., et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging 2007, 28(12):1889-1903.
133. Sperling R. Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann N Y Acad Sci 2007, 1097:146-155.
134. Sperling R.A., Dickerson B.C., Pihlajamaki M., et al. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 2010, 12(1):27-43.
135. Celone K.A., Calhoun V.D., Dickerson B.C., et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci 2006, 26(40):10222-10231.
136. Johnson S.C., Schmitz T.W., Moritz C.H., et al. Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment. Neurobiol Aging 2006, 27(11):1604-1612.
137. Petrella J.R., Wang L., Krishnan S., et al. Cortical deactivation in mild cognitive impairment: high-field-strength functional MR imaging. Radiology 2007, 245(1):224-235.
138. Satterthwaite T.D., Green L., Myerson J., et al. Dissociable but inter-related systems of cognitive control and reward during decision making: evidence from pupillometry and event-related fMRI. Neuroimage 2007, 37(3):1017-1031.
139. Vannini P., Hedden T., Becker J.A., et al. Age and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiol Aging 2012, 33(7):1237-1252.
140. Fleisher A.S., Sherzai A., Taylor C., et al. Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer's disease risk groups. Neuroimage 2009, 47(4):1678-1690.
141. Pihlajamaki M., O'Keefe K., O'Brien J., et al. Failure of repetition suppression and memory encoding in aging and Alzheimer's disease. Brain Imaging Behav 2011, 5(1):36-44.
142. Pihlajamaki M., O'Keefe K., Bertram L., et al. Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease. Alzheimer Dis Assoc Disord 2010, 24(1):28-36.
143. Pihlajamaki M., DePeau K.M., Blacker D., et al. Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. Am J Geriatr Psychiatry 2008, 16(4):283-292.
144. Greicius M.D., Srivastava G., Reiss A.L., et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 2004, 101(13):4637-4642.
145. Greicius M.D., Supekar K., Menon V., et al. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex 2009, 19(1):72-78.
146. Sorg C., Riedl V., Muhlau M., et al. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A 2007, 104(47):18760-18765.
147. Wang K., Liang M., Wang L., et al. Altered functional connectivity in early Alzheimer's disease: a resting-state fMRI study. Hum Brain Mapp 2007, 28(10):967-978.
148. Wermke M., Sorg C., Wohlschlager A.M., et al. A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2008, 35(Suppl 1):S12-S24.
149. Petrella J.R., Sheldon F.C., Prince S.E., et al. Default mode network connectivity in stable vs progressive mild cognitive impairment. Neurology 2011, 76(6):511-517.
150. Kukolja J., Thiel C.M., Fink G.R. Cholinergic stimulation enhances neural activity associated with encoding but reduces neural activity associated with retrieval in humans. J Neurosci 2009, 29(25):8119-8128.
151. Goekoop R., Scheltens P., Barkhof F., et al. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation-a pharmacological fMRI study. Brain 2006, 129(Pt 1):141-157.
152. Rombouts S.A., Barkhof F., Van Meel C.S., et al. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatr 2002, 73(6):665-671.
153. Saykin A.J., Wishart H.A., Rabin L.A., et al. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 2004, 127(Pt 7):1574-1583.
154. Shanks M.F., McGeown W.J., Forbes-McKay K.E., et al. Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease. Magn Reson Imaging 2007, 25(6):848-859.
155. Sperling R. Potential of functional MRI as a biomarker in early Alzheimer's disease. Neurobiol Aging 2011, 32(Suppl 1):37-43.
156. Goldberger A.L., Amaral L.A., Hausdorff J.M., et al. Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci U S A 2002, 99(Suppl 1):2466-2472.
157. Goldberger A.L., Peng C.K., Lipsitz L.A. What is physiologic complexity and how does it change with aging and disease?. Neurobiol Aging 2002, 23(1):23-26.
158. Andrzejak R.G., Widman G., Lehnertz K., et al. The epileptic process as nonlinear deterministic dynamics in a stochastic environment: an evaluation on mesial temporal lobe epilepsy. Epilepsy Res 2001, 44(2-3):129-140.
159. Osowski S., Swiderski B., Cichocki A., et al. Epileptic seizure characterization by Lyapunov exponent of EEG signal. Comput Methods Programs Biomed 2007, 26(5):1276-1287.
160. Stam C.J., Montez T., Jones B.F., et al. Disturbed fluctuations of resting state EEG synchronization in Alzheimer's disease. Clin Neurophysiol 2005, 116(3):708-715.
161. Kiselev V.G., Hahn K.R., Auer D.P. Is the brain cortex a fractal?. Neuroimage 2003, 20(3):1765-1774.
162. Zhang L., Liu J.Z., Dean D., et al. A three-dimensional fractal analysis method for quantifying white matter structure in human brain. J Neurosci Methods 2006, 150(2):242-253.
163. Esteban F.J., Sepulcre J., de Mendizabal N.V., et al. Fractal dimension and white matter changes in multiple sclerosis. Neuroimage 2007, 36(3):543-549.
164. Esteban F.J., Padilla N., Sanz-Cortes M., et al. Fractal-dimension analysis detects cerebral changes in preterm infants with and without intrauterine growth restriction. Neuroimage 2010, 53(4):1225-1232.
165. King R.D., George A.T., Jeon T., et al. Characterization of atrophic changes in the cerebral cortex using fractal dimensional analysis. Brain Imaging Behav 2009, 3(2):154-166.
166. King R.D., Brown B., Hwang M., et al. Fractal dimension analysis of the cortical ribbon in mild Alzheimer's disease. Neuroimage 2010, 53(2):471-479.
167. Takahashi T., Murata T., Narita K., et al. Multifractal analysis of deep white matter microstructural changes on MRI in relation to early-stage atherosclerosis. Neuroimage 2006, 32(3):1158-1166.
168. Takahashi T., Murata T., Omori M., et al. Quantitative evaluation of age-related white matter microstructural changes on MRI by multifractal analysis. J Neurol Sci 2004, 225(1-2):33-37.
169. Maxim V., Sendur L., Fadili J., et al. Fractional Gaussian noise, functional MRI and Alzheimer's disease. Neuroimage 2005, 25(1):141-158.
170. Sokunbi M.O., Staff R.T., Waiter G.D., et al. Inter-individual differences in fMRI entropy measurements in old age. IEEE Trans Biomed Eng 2011, 58(11):3206-3214.
171. Pievani M., de Haan W., Wu T., et al. Functional network disruption in the degenerative dementias. Lancet Neurol 2011, 10(9):829-843.
172. Ewers M., Frisoni G.B., Teipel S.J., et al. Staging Alzheimer's disease progression with multimodality neuroimaging. Prog Neurobiol 2011, 95(4):535-546.
173. Landman B.A., Huang A.J., Gifford A., et al. Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage 2011, 54(4):2854-2866.
174. Casanova R., Srikanth R., Baer A., et al. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 2007, 34(1):137-143.
175. Oakes T.R., Fox A.S., Johnstone T., et al. Integrating VBM into the General Linear Model with voxelwise anatomical covariates. Neuroimage 2007, 34(2):500-508.
176. Yang X., Beason-Held L., Resnick S.M., et al. Biological parametric mapping with robust and non-parametric statistics. Neuroimage 2011, 57(2):423-430.
177. Teipel S.J., Born C., Ewers M., et al. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage 2007, 38(1):13-24.
178. Plant C., Teipel S.J., Oswald A., et al. Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. Neuroimage 2010, 50(1):162-174.
179. Davatzikos C., Fan Y., Wu X., et al. Detection of prodromal Alzheimer's disease via pattern classification of MRI. Neurobiol Aging 2008, 29(4):514-523.
180. Orru G., Pettersson-Yeo W., Marquand A.F., et al. Using support vector machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev 2012, 36(4):1140-1152.
181. Misra C., Fan Y., Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009, 44(4):1415-1422.
182. Davatzikos C., Xu F., An Y., et al. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 2009, 132(Pt 8):2026-2035.
183. Zhang D., Shen D. Alzheimer's disease neuroimaging I. Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease. Neuroimage 2012, 59(2):895-907.
184. Zhang D., Shen D. Alzheimer's disease neuroimaging I. Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS One 2012, 7(3):e33182.
185. Teipel S.J., Ewers M., Wolf S., et al. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res 2011, 182(3):244-250.
186. Giannakopoulos P., Herrmann F.R., Bussiere T., et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003, 60(9):1495-1500.
187. Smith A.D. Commentary: imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci U S A 2002, 99(7):4135-4137.
188. Teipel S.J., Bokde A.L., Born C., et al. The morphological substrate of face matching in healthy aging and mild cognitive impairment: a combined MRI-fMRI study. Brain 2007, 130(Pt 7):1745-1758.
189. Jack C.R., Petersen R.C., Xu Y.C., et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997, 49:786-794.
190. Wang P.N., Lirng J.F., Lin K.N., et al. Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan. Neurobiol Aging 2006, 27(12):1797-1806.
191. Barnes J., Bartlett J.W., van de Pol L.A., et al. A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging 2009, 30(11):1711-1723.
192. Raz N., Rodrigue K.M., Head D., et al. Differential aging of the medial temporal lobe: a study of a five-year change. Neurology 2004, 62(3):433-438.
193. Rusinek H., De Santi S., Frid D., et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 2003, 229(3):691-696.
194. Kovacevic S., Rafii M.S., Brewer J.B. High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment. Alzheimer Dis Assoc Disord 2009, 23(2):139-145.
195. Antharam V., Collingwood J.F., Bullivant J.P., et al. High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron. Neuroimage 2012, 59(2):1249-1260.
196. Pluta J., Yushkevich P., Das S., et al. In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI. J Alzheimers Dis 2012, 31(1):85-99.
197. Stoub T.R., Bulgakova M., Leurgans S., et al. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 2005, 64(9):1520-1524.
198. Devanand D.P., Liu X., Tabert M.H., et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry 2008, 64(10):871-879.
199. Ezekiel F., Chao L., Kornak J., et al. Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus. Alzheimer Dis Assoc Disord 2004, 18(4):196-201.
200. Fox N.C., Cousens S., Scahill R., et al. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 2000, 57(3):339-344.
201. Schott J.M., Price S.L., Frost C., et al. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology 2005, 65(1):119-124.
202. Smith C.D., Chebrolu H., Wekstein D.R., et al. Brain structural alterations before mild cognitive impairment. Neurology 2007, 68(16):1268-1273.
203. Thompson P.M., Hayashi K.M., Dutton R.A., et al. Tracking Alzheimer's disease. Ann N Y Acad Sci 2007, 1097:183-214.
204. Lerch J.P., Pruessner J.C., Zijdenbos A., et al. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb Cortex 2005, 15(7):995-1001.